http://rdf.ncbi.nlm.nih.gov/pubchem/patent/OA-10025-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-27
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C315-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C319-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-02
filingDate 1994-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46fb9ff1f693303ee2c614dd5ce235b9
publicationDate 1996-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber OA-10025-A
titleOfInvention Crystallization of optical isomers of leukotriene antagonists
abstract This invention relates to certain salts of leukotriene antagonists and the use of a particular amine to form these salts as a means for selectively crystallizing optical isomers of the leukotriene antagonists disclosed herein.
priorityDate 1991-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426219397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455585947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15930770
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393744
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426025815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457323082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419576432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4275592

Total number of triples: 44.